Literature DB >> 31236273

Post-transcriptional control of immune responses and its potential application.

Masanori Yoshinaga1, Osamu Takeuchi1.   

Abstract

Inflammation is the host response against stresses such as infection. Although the inflammation process is required for the elimination of pathogens, uncontrolled inflammation leads to tissue destruction and inflammatory diseases. To avoid this, the inflammatory response is tightly controlled by multiple layers of regulation. Post-transcriptional control of inflammatory mRNAs is increasingly understood to perform critical roles in this process. This is mediated primarily by a set of RNA binding proteins (RBPs) including tristetraprolin, Roquin and Regnase-1, and RNA methylases. These key regulators coordinate the inflammatory response by modulating mRNA pools in both immune and local nonimmune cells. In this review, we provide an overview of the post-transcriptional coordination of immune responses in various tissues and discuss how RBP-mediated regulation of inflammation may be harnessed as a potential class of treatments for inflammatory diseases.

Entities:  

Keywords:  RNA binding proteins; immune response; post‐transcriptional regulation; therapeutics

Year:  2019        PMID: 31236273      PMCID: PMC6580065          DOI: 10.1002/cti2.1063

Source DB:  PubMed          Journal:  Clin Transl Immunology        ISSN: 2050-0068


  4 in total

1.  Roquin is a major mediator of iron-regulated changes to transferrin receptor-1 mRNA stability.

Authors:  Victor M Corral; Eric R Schultz; Richard S Eisenstein; Gregory J Connell
Journal:  iScience       Date:  2021-03-26

Review 2.  Shaping the Innate Immune Response Through Post-Transcriptional Regulation of Gene Expression Mediated by RNA-Binding Proteins.

Authors:  Anissa Guillemin; Anuj Kumar; Mélanie Wencker; Emiliano P Ricci
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

Review 3.  Historical overview of the interleukin-6 family cytokine.

Authors:  Sujin Kang; Masashi Narazaki; Hozaifa Metwally; Tadamitsu Kishimoto
Journal:  J Exp Med       Date:  2020-05-04       Impact factor: 14.307

4.  Frontiers in antiviral therapy and immunotherapy.

Authors:  Steven M Heaton
Journal:  Clin Transl Immunology       Date:  2020-02-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.